Abstract
Objective: To compare two different laser strategies of panretinal photocoagulation for diabetic retinopathy. Methods: Single-center, randomized study including 41 eyes treated with 577-nm multispot laser with a 20-ms pulse duration (group 1) or a 532-nm single-spot laser with a 100-ms pulse duration (group 2). The outcomes included best-corrected visual acuity (BCVA) and imaging changes at baseline, 6 and 12 months, laser parameters, and results of subjective pain analysis. Results: At 12 months, the treatments did not differ significantly in BCVA, central retinal thicknesses (CRTs), improved macular edema, vitreomacular interface changes, patient-reported pain scores, or angiographic responses. Group 1 had significantly fewer treatment sessions but used more laser spots (p < 0.001). Conclusion: The multispot laser required fewer applications with more spots delivered to compensate for lower fluency, showing similar patient tolerance to single-spot laser. Both groups maintained the initial visual acuities and CRTs; about 50% of cases had vitreomacular interface changes and improved macular edema, with similar angiographic improvements after 12 months.
References
1.
The Diabetic Retinopathy Study Research Group
. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8
. Ophthalmology
. 1981
Jul
;88
(7
):583
–600
.
[PubMed]
0161-64202.
Early Treatment Diabetic Retinopathy Study Research Group
. Early photocoagulation for diabetic retinopathy. ETDRS report number 9
. Ophthalmology
. 1991
May
;98
(5
Suppl
):766
–85
.
[PubMed]
0161-64203.
Diabetic Retinopathy Clinical Research Network
. Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, Elman MJ, Ferris FL 3rd, Friedman SM, Marcus DM, Melia M, Stockdale CR, Sun JK, Beck RW: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial
. JAMA
. 2015
;314
:2137
–46
.0098-74844.
Sivaprasad
S
, Prevost
AT
, Vasconcelos
JC
, Riddell
A
, Murphy
C
, Kelly
J
, et al.; CLARITY Study Group
. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
. Lancet
. 2017
Jun
;389
(10085
):2193
–203
.
[PubMed]
0140-67365.
Hutton
DW
, Stein
JD
, Bressler
NM
, Jampol
LM
, Browning
D
, Glassman
AR
; Diabetic Retinopathy Clinical Research Network
. Cost-effectiveness of intravitreous ranibizumab compared with panretinal photocoagulation for proliferative diabetic retinopathy
. JAMA Ophthalmol
. 2017
Jun
;135
(6
):576
–84
.
[PubMed]
2168-61656.
Lin
J
, Chang
JS
, Smiddy
WE
. Cost evaluation of panretinal photocoagulation versus intravitreal ranibizumab for proliferative diabetic retinopathy
. Ophthalmology
. 2016
Sep
;123
(9
):1912
–8
.
[PubMed]
0161-64207.
Li
X
, Zarbin
MA
, Bhagat
N
. Anti-vascular endothelial growth factor injections: the new standard of care in proliferative diabetic retinopathy?
Dev Ophthalmol
. 2017
;60
:131
–42
.
[PubMed]
0250-37518.
Silva
PA
, Cavallerano
JD
, Sun
JK
, Blodi
BA
, Davis
MD
, Aiello
LM
, et al. Proliferative Diabetic Retinopathy. Ryan SJ: Retina Volume Two: Medical Retina
. 5th ed. Atlanta (GA)
: Elsevier Saunders
; 2013
. pp. 969
–1000
.9.
Muqit
MM
, Marcellino
GR
, Henson
DB
, Young
LB
, Patton
N
, Charles
SJ
, et al. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study
. Arch Ophthalmol
. 2010
May
;128
(5
):525
–33
.
[PubMed]
0003-995010.
Muqit
MM
, Gray
JC
, Marcellino
GR
, Henson
DB
, Young
LB
, Patton
N
, et al. In vivo laser-tissue interactions and healing responses from 20- vs 100-millisecond pulse Pascal photocoagulation burns
. Arch Ophthalmol
. 2010
Apr
;128
(4
):448
–55
.
[PubMed]
0003-995011.
Hirano
T
, Iesato
Y
, Imai
A
, Toriyama
Y
, Kikushima
W
, Murata
T
. Effect of Laser wavelength on delivering appropriate laser burns through the opaque lens using a pattern scan laser
. Ophthalmic Res
. 2014
;51
(4
):204
–9
.
[PubMed]
0030-374712.
Yadav
NK
, Jayadev
C
, Mohan
A
, Vijayan
P
, Battu
R
, Dabir
S
, et al.; Medscape
. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome
. Eye (Lond)
. 2015
Feb
;29
(2
):258
–64
.
[PubMed]
0950-222X13.
Kim
JY
, Park
HS
, Kim
SY
. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy
. Graefes Arch Clin Exp Ophthalmol
. 2015
Dec
;253
(12
):2129
–35
.
[PubMed]
0721-832X14.
Kwon
YH
, Lee
DK
, Kwon
OW
. The short-term efficacy of subthreshold Micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema
. Korean J Ophthalmol
. 2014
Oct
;28
(5
):379
–85
.
[PubMed]
1011-894215.
Sramek
CK
, Leung
LS
, Paulus
YM
, Palanker
DV
. Therapeutic window of retinal photocoagulation with green (532-nm) and yellow (577-nm) lasers
. Ophthalmic Surg Lasers Imaging
. 2012
Jul
;43
(4
):341
–7
.
[PubMed]
1542-887716.
Vujosevic
S
, Martini
F
, Longhin
E
, Convento
E
, Cavarzeran
F
, Midena
E
. Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macular edema
. Retina
. 2015
;35
(8
):1594
–603
.
[PubMed]
0275-004X17.
Melzack
R
, Katz
J
. Pain Measurement in Adult Patients. McMahon SB: Wall and Melzack’s Textbook of Pain
. 6th ed. Atlanta (GA)
: Elsevier Saunders
; 2013
. pp. 301
–14
.18.
Chappelow
AV
, Tan
K
, Waheed
NK
, Kaiser
PK
. Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser
. Am J Ophthalmol
. 2012
Jan
;153
(1
):137
–42.e2
.
[PubMed]
0002-939419.
Nagpal
M
, Marlecha
S
, Nagpal
K
. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser
. Retina
. 2010
Mar
;30
(3
):452
–8
.
[PubMed]
0275-004X20.
Mainster
MA
. Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems
. Ophthalmology
. 1986
Jul
;93
(7
):952
–8
.
[PubMed]
0161-642021.
Vogel
M
, Schäfer
FP
, Stuke
M
, Müller
K
, Theuring
S
, Morawietz
A
. Animal experiments for the determination of an optimal wavelength for retinal coagulations
. Graefes Arch Clin Exp Ophthalmol
. 1989
;227
(3
):277
–80
.
[PubMed]
0721-832X22.
Blumenkranz
MS
, Yellachich
D
, Andersen
DE
, Wiltberger
MW
, Mordaunt
D
, Marcellino
GR
, et al. Semiautomated patterned scanning laser for retinal photocoagulation
. Retina
. 2006
Mar
;26
(3
):370
–6
.
[PubMed]
0275-004X23.
Palanker
D
, Lavinsky
D
, Blumenkranz
MS
, Marcellino
G
. The impact of pulse duration and burn grade on size of retinal photocoagulation lesion: implications for pattern density
. Retina
. 2011
Sep
;31
(8
):1664
–9
.
[PubMed]
0275-004X24.
Friberg
TR
, Venkatesh
S
. Alteration of pulse configuration affects the pain response during diode laser photocoagulation
. Lasers Surg Med
. 1995
;16
(4
):380
–3
.
[PubMed]
0196-809225.
Al-Hussainy
S
, Dodson
PM
, Gibson
JM
. Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times
. Eye (Lond)
. 2008
Jan
;22
(1
):96
–9
.
[PubMed]
0950-222X26.
Muqit
MM
, Marcellino
GR
, Gray
JC
, McLauchlan
R
, Henson
DB
, Young
LB
, et al. Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2
. Br J Ophthalmol
. 2010
Nov
;94
(11
):1493
–8
.
[PubMed]
0007-116127.
Mirshahi
A
, Lashay
A
, Roozbahani
M
, Fard
MA
, Molaie
S
, Mireshghi
M
, et al. Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy
. Graefes Arch Clin Exp Ophthalmol
. 2013
Apr
;251
(4
):1103
–7
.
[PubMed]
0721-832X28.
González-Saldivar
G
, Rojas-Juárez
S
, Espinosa-Soto
I
, Sánchez-Ramos
J
, Jaurieta-Hinojosa
N
, Ramírez-Estudillo
A
. Single-spot yellow laser versus conventional green laser on panretinal photocoagulation: patient pain scores and preferences
. Ophthalmic Surg Lasers Imaging Retina
. 2017
Nov
;48
(11
):902
–5
.
[PubMed]
2325-816029.
Bijur
PE
, Silver
W
, Gallagher
EJ
. Reliability of the visual analog scale for measurement of acute pain
. Acad Emerg Med
. 2001
Dec
;8
(12
):1153
–7
.
[PubMed]
1069-656330.
Sebag
J
, Nguyen-Cuu
J
. The effects of vitreous on proliferative diabetic retinopathy and the response to pan retinal photocoagulation
. Graefes Arch Clin Exp Ophthalmol
. 2017
Feb
;255
(2
):421
–2
.
[PubMed]
0721-832X31.
Akiba
J
, Arzabe
CW
, Trempe
CL
. Posterior vitreous detachment and neovascularization in diabetic retinopathy
. Ophthalmology
. 1990
Jul
;97
(7
):889
–91
.
[PubMed]
0161-642032.
Sebag
J
, Buzney
SM
, Belyea
DA
, Kado
M
, McMeel
JW
, Trempe
CL
. Posterior vitreous detachment following panretinal laser photocoagulation
. Graefes Arch Clin Exp Ophthalmol
. 1990
;228
(1
):5
–8
.
[PubMed]
0721-832X33.
Bressler
SB
, Beaulieu
WT
, Glassman
AR
, Gross
JG
, Jampol
LM
, Melia
M
, et al.; Diabetic Retinopathy Clinical Research Network
. Diabetic Retinopathy Clinical Research Network: factors Associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab
. Ophthalmology
. 2017
Apr
;124
(4
):431
–9
.
[PubMed]
0161-6420© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
